(NASDAQ: DCTH) Delcath Systems's forecast annual revenue growth rate of 19.03% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.53%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.42%.
Delcath Systems's revenue in 2026 is $95,418,000.On average, 8 Wall Street analysts forecast DCTH's revenue for 2026 to be $3,769,677,089, with the lowest DCTH revenue forecast at $3,577,792,752, and the highest DCTH revenue forecast at $3,934,843,353. On average, 8 Wall Street analysts forecast DCTH's revenue for 2027 to be $4,734,303,590, with the lowest DCTH revenue forecast at $4,381,416,845, and the highest DCTH revenue forecast at $5,033,754,191.
In 2028, DCTH is forecast to generate $5,560,828,887 in revenue, with the lowest revenue forecast at $4,665,599,976 and the highest revenue forecast at $6,218,718,040.